ligands acting on targets

(+)-Borneol.

(+)-Borneol.

(+)-Bulbocapnine hydrochloride is a dopamine inhibitor that is also the water-soluble form of (+)-Bulbocapnine.

(+)-butaclamol.

(+)-butaclamol.

(+)-Butaclamol hydrochloride is a D2DR inhibitor. Studies on rat striatal Homovanillic acid concentrations indicate that (+)-Butaclamol hydrochloride increases the concentration of this compound, via D2DR antagonism. In addition, these studies

(+)-Catechin.

(+)-Cevimeline hydrochloride hemihydrate ((+)-SNI-2011), a potent muscarinic receptor agonist, is a candidate therapeutic drug for xerostomia in Sjogren's syndrome./nIC50 value:/nTarget: mAChR The general pharmacol. properties of this drug on the

(+)-Cevimeline hydrochloride hemihydrate ((+)-SNI-2011), a potent muscarinic receptor agonist, is a candidate therapeutic drug for xerostomia in Sjogren's syndrome./nIC50 value:/nTarget: mAChR The general pharmacol. properties of this drug on the

(+)-Cevimeline hydrochloride hemihydrate ((+)-SNI-2011), a potent muscarinic receptor agonist, is a candidate therapeutic drug for xerostomia in Sjogren's syndrome./nIC50 value:/nTarget: mAChR The general pharmacol. properties of this drug on the

(+)-chlorpheniramine.

(+)-chlorpheniramine.